It is a pharma private limited company based in New Delhi, Delhi, India, established in 2010.
2010 | New Delhi, Delhi, India | ActiveStardom Pharmaceuticals Private Limited, a active private limited company, was established on 14 December 2010 in New Delhi, Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232DL2010PTC211417. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Rajeev Ranjan (Additional Director), Nikhil Kumar (Director), Alok Ranjan (Additional Director). Past directors included Madhu Ranjit Sharma, Ranjit Kumar Sharma, Nikhil Kumar. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at M-54 Ground Floor Kalkaji, New Delhi, Delhi, 110019.
U24232DL2010PTC211417
211417
14 December 2010
₹0.50 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Stardom Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajeev Ranjan | Additional Director | 16 May 2025 | Current |
| Nikhil Kumar | Director | 19 Jun 2024 | Current |
| Alok Ranjan | Additional Director | 27 Mar 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 03 Sep 2015 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 03 Dec 2021 | Past |
| Pramod Abcsdd | Director | 03 Dec 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Stardom Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 351.84% increase. The company also saw a substantial improvement in profitability, with a 434.59% increase in profit. The company's net worth Soared by an impressive increase of 37.8%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Stardom Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Stardom Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Stardom Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stardom Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Rajeev Ranjan was appointed as a Additional Director was appointed as a Additional Director on 16 May 2025 & has been associated with this company since 7 months 4 days . was documented.
Alok Ranjan was appointed as a Additional Director was appointed as a Additional Director on 27 Mar 2025 & has been associated with this company since 8 months 23 days . was recorded as a recent event.
The activity Stardom Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Nikhil Kumar was appointed as a Director was appointed as a Director on 19 Jun 2024 & has been associated with this company since 1 year 6 months . was recorded as a recent event.
Stardom Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The activity Stardom Pharmaceuticals Private Limited was registered on 14 Dec 2010 with Roc Delhi & aged 15 years 5 days as per MCA records. was completed.
The CIN of Stardom Pharmaceuticals Private Limited is U24232DL2010PTC211417.
Stardom Pharmaceuticals Private Limited is headquartered at M-54 Ground Floor Kalkaji, New Delhi, Delhi, 110019.
Stardom Pharmaceuticals Private Limited was incorporated on 14 December 2010.
The current directors of Stardom Pharmaceuticals Private Limited are
The primary industry of Stardom Pharmaceuticals Private Limited is Trade.
Stardom Pharmaceuticals Private Limited is unlisted.
The authorized capital of Stardom Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Stardom Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX